Medicinal Cannabis Market Size ,Share and Forecast upto 2024

Medicinal cannabis, also known as medicinal marijuana, is used either to treat disease or improve symptoms. Cannabis has been considered to be a major source of drug addiction. Extract from the dried flower bud part of the plant called as Marijuana has certain medicinal properties. The two cannabinoids – delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are being used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.

Other names of Cannabis– grass, pot, dope, Mary Jane, hooch, weed, hash, joints, brew, reefers, cones, smoke, mull, buddha, ganga, hydro, yarndi, heads, and green.

The U.S. FDA has approved two medications, Marinol and Syndros, which contain dronabinol in pill form. However, the FDA has not approved the marijuana plant as a medicine. The medicinal cannabis (marijuana) is administered in either of the ways – liquid extract, vaporized form, smoked or solid form.

Medicinal Cannabis Market Dynamics

However, the debate still continues regarding the approval, safety and usage of cannabis (marijuana) for medicinal purpose, due to differences in the laws pertaining to this smoked drug. Hence, studies are conducted extensively to establish the safety aspect of this drug. Various states in the U.S. have already legalized cannabis (marijuana) for medicinal purposes. Scientific research of chemicals in the cannabis plant for its potential medicinal use has led to a shift in its demand purpose. Regulatory clearance has played a major role in the growth of medicinal cannabis market.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/40

Prevalent Scenario in the Medicinal Cannabis Market

According to the Medical Marijuana, Inc., the estimated size of the legal marijuana industry in the U.S. is US$ 7.1 billion in 2016. This is an increase of 25% Y-o-Y. As of 2016, 28 states in the U.S. have legalized marijuana for medicinal purpose with some more gearing up for votes on the recreational use of marijuana. California, Nevada, Maine, and Massachusetts states in November 2016, voted to legalize the recreational use of marijuana. The accelerated pace of legalization of cannabis (marijuana) in the U.S. has attracted the attention of global investors in the medicinal cannabis market. However, lack of formulation of a comprehensive law pertaining to medicinal marijuana in some states inhibits patient access to the drug.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/40

Medicinal Cannabis Market Future Outlook

Potential medicinal cannabis markets other than the U.S., include Canada, Israel, Australia, and Spain. Mexico is also in process to consider the legalization of cannabis. Other countries are expected to consider legalization of the drug, once conclusive evidence regarding the safety and efficacy of cannabis are obtained through extensive research. According to Arcview Group—a cannabis industry investment and research firm—around 200 investors met companies to capitalize on lucrative opportunities from commercialization of medicinal cannabis. This implies that there is a huge potential in the medicinal cannabis industry and pharmaceutical and biotechnology companies need to focus on increasing awareness about the drug emerging economies.

Important role of Regulatory Authorities in the Medicinal Cannabis Market Trends

According to the United Nations, marijuana was the most widely used drug globally in 2014, with around 183 million users. Such a large user base makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding legalization of the drug for medicinal use. The National Institute on Drug Abuse is still conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune disease, pain, inflammation, seizures, mental disorders, and substance abuse disorders. Regulatory compliance is a key factor that influences cost, quality, and safety of cannabis (marijuana) medicines, as well as the capacity for the manufacturers in the medical cannabis market to be responsive, scalable, and innovative.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Bleeding Disorders Treatment Market Size , Share and Forecast upto 2025

Bleeding Disorders Treatment Market:

A bleeding disorder is a state in which the normal clotting function of blood is adversely affected. On an injury to the body, blood normally starts to clot to prevent major loss of blood. Occasionally, certain situations prevent blood from clotting properly, which can result in heavy or prolonged bleeding. Bleeding disorders can cause abnormal bleeding both outside and inside of the body. Some disorders can drastically increase the amount of blood lost by the body. Others cause bleeding to follow under the skin or in vigorous organs, such as the brain. Normal blood clotting involves blood components called ‘platelets’ and as many as there are 20 different plasma proteins in body called as blood clotting or coagulation factors. These factors interact with other chemicals to form a substance called fibrin which stops bleeding. Complications can occur when certain factors are low or missing in body. Bleeding problems can range from mild to severe. Some bleeding disorders are present at time of birth and some are passed through families (inherited).

According to American Society of Hematology, in 2016, around 20,000 people in the U.S. suffer from hemophilia, a condition that is predominantly observed in males. Hemophilia is the most well-known inherited bleeding disorder, although it is rather rare. On the other hand, many people are affected by von Willebrand disease, the most common inherited bleeding disorder in the U.S. caused by clotting proteins. This disease can affect both males and females and is found in nearly 1% of the U.S. population. And according to the Centers for Disease Control and Prevention (CDC) statistics, in the U.S. around 400 newborns suffer from hemophilia every year.

Get an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/527

Bleeding Disorders Treatment Market

On the basis of type of disorder, the global bleeding disorders treatment market is classified into:

  • Hemophilia A

  • Hemophilia B

  • von Willebrand Disease (vWD)

On the basis of drug class, the global bleeding disorders treatment market is classified into:

  • Plasma Derived Coagulation Factor Concentrates

  • Recombinant Coagulation Factor Concentrate

  • Desmopressin

  • Antifibrinolytics

  • Fibrin sealants

  • Others

Generic products to be the growth factor for bleeding disorders treatment market

The bleeding disorder treatment market is driven by the large customer base, growing awareness about the bleeding disorders and available cures, and favorable compensation policies. Patent expiry of existing brands will also provide generic drug manufacturers opportunities to enter the lucrative bleeding disorder therapeutics market. Market for bleeding disorder treatment is mostly focused towards western countries of North America and Europe, owing to the high price of branded drugs. Low cost drugs will help in market penetration in under developed and developing countries, where patients cannot afford high cost of medical treatment.  Hence, availability of cheap generic drugs will boost market growth in the countries of Middle East and Africa, Asia-Pacific (APAC), and Latin America.

North America is estimated to contribute the largest share of the market throughout the forecast period. The market in APAC is estimated to register the highest growth during the forecast period, owing to increasing awareness of these disorders in the emerging economies such as India and China.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/527

The global bleeding disorder treatment market is highly competitive in nature. Technological advances will expand the boundaries of the market by adding new products such as Shire launched Vonvendi in the U.S. (In 2016), bringing the first recombinant von Willebrand factor treatment to market eight months after winning approval from the Food and Drug Administration(FDA). Key players operating in the global bleeding disorders treatment market are Bayer Healthcare, Biogen Idec, Novo Nordisk, Xenetic Biosciences, Shire, Sanofi, Cangene Corporation, CSL Behring, Alnylam Pharmaceuticals, Pfizer, Inc., Novo Nordisk, Amgen, Inc., Janssen Pharmaceuticals, and Octapharma.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Anesthesia and Respiratory Devices Market Size ,Share and Forecast upto 2025

Anesthesia and Respiratory Devices Market Overview:

Anesthesia is a state in which a person has temporary induced loss of sensation or awareness provided by the anesthesia devices. Anesthesia device provide accurate and continuous supply of medical gases mixed with an accurate concentration of anesthetic vapor. Anesthesia provides painless performance of medical procedures that could serve intolerable pain to an un-anesthetized patient. There are three types of anesthesia general anesthesia, sedation anesthesia and regional or local anesthesia. While respiratory devices are used to provide medication or to comfort patient who have difficulty in breathing and cannot acquire sufficient level of oxygen to maintain life. Patient with respiratory disease use various respiratory devices that help to remove the mucus from the airway and improve the function of pulmonary. Respiratory devices lead the market as compared with anesthesia device as anesthesia devices has limited end user.

Furthermore, increase in aging population who suffer from asthma, pulmonary disease and chronic obstructive pulmonary disease is expected to favor the anesthesia and respiratory device market. According to world ageing population reports in the U.S. between 2015 and 2030, the number of people in the world aged 60 years or over is projected to grow by 56 per cent, from 901 million to 1.4 billion, and by 2050, the global population of older persons is projected to more than double its size in 2015, reaching nearly 2.1 billion. Increase in number of surgeries worldwide also fuels the anesthesia and respiratory device market. Moreover, continuous technical advancement in anesthesia and respiratory devices is another driving force for the growth of market.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/532

Anesthesia and respiratory devices market taxonomy

By Product Type

  • Anesthesia Devices

  • Anesthesia Machines

  • Anesthesia Disposables

  • Respiratory Devices

  • Respiratory Equipment

  • Respiratory Disposables

  • Respiratory Measurement Devices

By End User

  • Anesthesia Devices

  • Hospital

  • Ambulatory Surgical Centers

  • Respiratory Devices

  • Hospital

  • Ambulatory Surgical Centers

  • Homecare Settings

Rise in number of surgeries fuel the anesthesia and respiratory device market

Anesthesia devices are used commonly in all types of surgeries as they are designed to provide an accurate and continuous supply of mixed medical gases with anesthetic vapors which is delivered to patient at a safe pressure and flow. According to Centers for Disease Control and Prevention in year 2010, 16 million operative procedures were performed in the U.S. whereas rise in number of patient who suffer from respiratory disease favors growth of the market. According to the Center for Disease Control and Prevention in year 2016 estimated that 24 million people, including more than 6 million children have asthma in the U.S.

Furthermore, demand for anesthesia devices are rapidly increased due to growth in safety awareness and technology enhancement. Moreover, Obstructive sleep apnea also favor the growth of market as this type of apnea occurs to throat muscles when they relax, which leads to blockage of airway during sleep and so to the treat OBA disorder respiratory devices are used.

Regional growth engines of the anesthesia and respiratory device market

In terms of geography anesthesia and respiratory device market is segmented into North America, Europe, Asia Pacific, Middle East, Latin America and Africa. Due to presence of high income and health awareness in North America favors the growth of market. Additionally, the leading cause of death in North America is chronic obstructive pulmonary disease (COPD) as it is the third leading cause of death in North America. The above statistics supports the growth of anesthesia and respiratory device market.

Furthermore, due to economic development, health reform by government and increase in investment in research and development in Asia Pacific region is expected to show growth in the market.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/532

The key players dominating the global anesthesia and respiratory device market

Providers in the market offer a broad range of anesthesia and respiratory device and introduction of low priced multi-featured devices in market is increasing the product competition in market within the manufactures. The key player operating the market of anesthesia and respiratory device includes Fisher & Paykel Healthcare, Invacare, GE Healthcare, Teleflex, Philips Healthcare, Drägerwerk AG, Medtronic, Smiths Medical, OSI systems and Getinge AB.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Acupuncture Lasers Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Acupuncture Lasers Market Overview:

Acupuncture lasers help relieve pain by a relatively novel method of stimulation. Laser acupuncture uses low-energy laser beams to influence the flow of current at the acupuncture points instead of traditional acupuncture needles. Biologically, the laser stimulation increase the cell production in the tissues, resulting in increased collagen production and blood circulation. Acupuncture laser has got more acceptability due to its non-invasive and painless properties. It is usually preferred for effective treatment of painful conditions such as carpal tunnel syndrome, tennis elbow, arthritis and chronic headache in children. Tissue healing, musculoskeletal disorders, neurological conditions, cardiovascular problems, respiratory conditions, digestive system disorders, gynecological problems, skin conditions, eye conditions, sports injuries, and psychological conditions are the common application areas of acupuncture lasers.

Asia Pacific main growth engine of acupuncture lasers market, dominated by China and Japan

One of the major factor driving the acupuncture laser market is the increasing chronic diseases. For instance, according to American Pain Foundation, 2006, chronic pain affected 100 million people in the U.S., which is more than the total affected by heart disease, cancer and diabetes. Increasing concern and awareness about health and growing number of diseases are the factors contributing to the growth of acupuncture Lasers market.

Get a trending sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/424

Innovations in Acupuncture lasers leads to an increase in the Acupuncture lasers market

Modern lasers used in acupuncture are known as cold-lasers, as they do not produce heat in comparison with the hot-lasers used for surgery. The cold-lasers offer a variety of advantages to help regenerate cells, decrease pain, improve circulation, reduce inflammation and stimulate hair growth. The miniaturization of individual systems plays a large role. The new laser watch applies laser acupuncture and laser blood irradiation has played a large role.

Advent of carbon source lasers are expected to boost the acupuncture laser market over the forecast period

The global acupuncture laser market is segmented on the basis of product type, mechanism of action, end use and geography.

On the basis of product type, the acupuncture laser market is segmented into:

  1. Carbon source
  2. Helium Neon light source
  3. Semiconductor source
  4. Yttrium Aluminum Garnet(YAG) laser

On the basis of pumping action, the acupuncture laser market is segmented into:

  1. Optically pumper laser
  2. Electrically pumped laser
  3. Continuous pumped laser
  4. Pulsed laser

On the basis of end user application, the acupuncture laser market is segmented into:

  1. Hospitals
  2. Beauty clinics
  3. Others

The highest number of cosmetic surgeries in North America will dominates the Acupuncture laser market

Regional segmentation of the acupuncture laser market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to the National Commission for Acupuncture and Oriental Medicine survey conducted in 2004, 30 million people in the U.S. have tried acupuncture and hence, North America is expected to hold largest share in the acupuncture laser market. In 2001, according to The Members of the British Acupuncture Council survey in 2001, the physical, emotional, mental symptoms were relieved in 75% patients.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/424

RJ Laser is universal modular system offering high-end compact laser

Key players operating acupuncture laser market have used strategies like expansions, joint ventures, acquisitions, partnerships are Sedatelac, Hwato, Schwa-medico GmbH, Acupressure Health Care, MKW Laser system, Mectronic Medicale. RJ laser devices stand out due to the modern compact design and high level of efficiency. Physiomed Elektromedizin , Reimers & Janssen GmbH, Sorisa, Globus Italia, Iskra Medical, Fysiomed, Erchonia, StarMed Tec GmbH, Cymedics are the other prominent companies leading the market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Ulcerative Colitis Market Size , Share and Forecast upto 2024

Ulcerative Colitis Market Overview:

Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained weight loss, loss of appetite, joint pain, eye disease, thickening of the intestinal wall, blood infection (sepsis), kidney stones and liver disease. The diagnosis of this disease can be carried out by physical examination using tests such as colonoscopy, endoscopy, biopsy, CT scan and blood test.

If ulcerative colitis persists for over 8 years or longer, it may lead to colon cancer. The people having mild symptoms of this disease can be cured by over the counter drugs such as Imodium therapy. However, transcription medicine such as steroid medicines and amino salicylates are widely used to treat the condition. In severe cases, the patient may need to undergo surgery to remove the colon, which also helps prevent colon cancer.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/238

Also, some genetically engineered drugs also used to treat ulcerative colitis. These drugs are made up of certain living organisms that help suppress the inflammation, by targeting the inflammatory proteins such as cytokines. Some genetically engineered drugs approved by the U.S. FDA for treatment of the condition are Adalimumab (Humira), Golimumab (Simponi), Infliximab (Remicade) and Vedolizumab (Entyvio).

These genetically engineered drugs may show some side effects such as fever, headache, hives, low blood pressure, breathing difficulties, back pain, and stomach pain. Also, these drugs may affect the immunity power of body to fight infection.

The exact cause for ulcerative colitis is unknown, though possible reasons are may be genetic factors, environmental changes, or weakened immune system. The ulcerative colitis can be prevented by simple healthy habits such as eating small meals throughout the day, staying well hydrated throughout the day, avoiding fatty foods, and limiting intake of high-fiber food.

According to data released by the Centers for Disease Control and Prevention (CDC), there are around 2.2 to 14.3 cases found per 100,000 population per year. Also, according to a study conducted in 2014 by Crohn’s & Colitis Foundation of America (CCFA), 907,000 people suffered from ulcerative colitis in the U.S. (data based on the research conducted in between 2011-2014 by CCFA)

Ulcerative colitis market taxonomy:

Global Market by Drug Type

  • Infliximab

  • Golimumab

  • Adalimumab

  • Vedolizumab

  • Mesalamine

  • Budesonide

  • Balsazide

Global Market by Dosage Form

  • Parenteral

  • Oral

Global Market by Geography

  • North America

  • Europe

  • APAC

  • Latin America

  • Middle East

  • Africa

High prevalence in developed regions and increasing incidence rate in emerging economies will play major role in driving growth of the ulcerative colitis market

According to the study of CCFA, industrialized countries have highest incidence rate for ulcerative colitis. This disease is most prevalent in urban areas than in rural areas, also it can affect to any age group of people but most cases diagnosed are of the age in between 15 to 35. According the stats of World Gastroenterology Organization (WGO), there is rising incidence rate in emerging economies such as India. Due to changing diet and lifestyle pattern, the emerging economies will show high growth rate in incidence rate of ulcerative colitis in the near future.

According to data collected from various sources and compiled by Coherent Market Insights, Europe have the highest annual rate of incidence worldwide, followed by North America and the lowest in Asia and Middle East.

However, North America holds the largest share in the global ulcerative colitis market due to continuous improvements in drugs, increased uptake of medicines, awareness about treatment and increasing clinical research. APAC region will show high growth in ulcerative colitis market during forecast years (2017-2024), due to raising awareness about the treatment, changing lifestyle will cause to increase prevalence and incidence rate, entry of new drugs in the market also some companies losing their patent of ulcerative drugs in coming years, like Humira (adalimumab) lost its patent in 2016 and Remicade will lose its patent in 2018. Also, some drugs companies have launched their biosimilar drugs in ulcerative colitis industry. For example, in 2016, India-based Torrent Pharmaceuticals launched a biosimilar drug under the brand name Adfra to compete Humira. Humira is a trade name for adalimumab medication owned by AbbVie Inc.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/238

Some major companies playing leading role in ulcerative colitis market are AbbVie Inc., Hospira, Celltrion Healthcare, Johnson and Johnson, F. Hoffmann-La Roche AG, Warner Chilcott, Janssen Pharmaceuticals Inc. and Takeda Pharmaceuticals Company Ltd.

Some leading drugs are used to reduce inflammation and swelling and to cure ulcerative colitis are include Sulfasalazine (Azulfidine), Mesalamine (Asacol and Lialda), Balsalazide (Colazal), and Olsalazine (Dipentum), Inflectra, Remsima, Adalimumab (Humira), Infliximab (Remicade).

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Nephrology and Urology Devices Market Size , Share and Forecast upto 2024

Nephrology and Urology Devices Market Overview :

Nephrology and urology devices are used to treat ailments related to the urinary system, such as chronic kidney disease, kidney stone, urinary incontinence, and end stage renal disease. According to the Global Burden Disease study which was conducted in 2015, chronic kidney disease is ranks as the 17th leading cause of death globally. In many developed countries, chronic kidney disease ranks as the 5th leading cause of death. Kidney stones have become an epidemic in U.S. with a prevalence rate of 8.8% as per the statistics released by National Kidney Foundation. According to the study conducted by Rajiv Gandhi University of Health Sciences, an estimated 5-7 million people suffer from kidney stone disease in India. With the advancement in technology, the adoption of innovative Nephrology and Urology devices has increased significantly.

Novel technologies such as wearable medical devices and Short wave lithotripsy are foraying into market

Nephrology and Urology devices market is undergoing a wave of transformation, as key players are introducing innovative products into the market in order to differentiate their product offerings. The rise in healthcare expenditure in developed economies such as the U.S. and China has had a positive impact on growth of the market. Wearable artificial kidney has been a revolution in the nephrology and urology devices market. Wearable artificial kidney has the potential to provide minimally invasive dialysis technology. In 2016, Linux Hospital conducted clinical trials for wearable artificial kidney and it concluded that the technology will be able to provide dialysis for patients in home settings and remote locations. Short wave lithotripsy is a minimally invasive procedure that is used to remove kidney stones. The technique was first used in 1980 and today it has become an essential part of the market. The market will witness strong growth during the forecast period as the demand for minimally invasive products increases.

Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/244

Nephrology and Urology market will experience high growth in the Asia Pacific region

Europe is the largest market with respect to geography for the nephrology and urology market due to large population base and presence of key players in the region. According to the data published by European Association of Urology, one in ten people suffer from kidney stones in Europe. This is attributed to the shift towards unhealthy lifestyle which has led to high prevalence of obesity. The association further stated that an estimated 55 million people are currently suffering from kidney stone in Europe. North America is the second largest market for Nephrology and Urology market. As per the data released by U.S. renal data system, 468,000 patients underwent dialysis in 2013 which shows an astonishing 47% increase in the patient pool over 40 years. With the increase in aging population and rise in prevalence of obesity, the market for Nephrology and Urology devices market is estimated to grow in North America.

Asia Pacific countries such as China and India constitute significant patient population for nephrology and urology devices. According to National Kidney Foundation, the cases for kidney failure will increase substantially in countries such as China in the near future as the geriatric population surges. As per an independent study conducted in India, 16% of the population suffers from renal disease. As the patient pool increases coupled with improving healthcare infrastructure, the demand for novel nephrology and urology devices will increase.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/244

The key players in the Nephrology and Urology devices market are competing by acquiring small players to gain market share

The key players in the Nephrology and Urology devices market are Boston Scientific Corporation, Cook Medical, Fresenius Medical Care, Baxter International, American Medical Systems and Olympus Medical Systems. The market has witnessed the entry of new players which are able to offer innovative products at competitive pricing. The key companies have adopted mergers and acquisition strategy to gain market share and maintain dominant position in the nephrology and urology devices industry. For instance, Baxter International completed the acquisition of Gambro in 2013. The market is expected to witness consolidation as the large companies continue to acquire small players to expand their product portfolio and geographic presence.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

The Global Gamma Knife Market is projected to expand at a CAGR of 7.7% during the forecast period (2017–2025)

Gamma knife is an outpatient procedure that allows the patient to travel back home the same day of treatment. Gamma knife is a highly focused radiation therapy for brain or spinal cancer involving a single treatment high-dose radiation therapy. Cyberknife on the other hand, which can treat cancer anywhere in the body, involves one to five radiation treatment capability. Gamma knife therapy is considered to be much safer than the open-skull surgeries owing to these factors. The global gamma knife market is expected to grow gradually with increase in awareness. There are more than 300 gamma knife centers worldwide at present, which are estimated to treat nearly 60,000 patients every year. However, there still exists a high demand-supply gap in the countries in pacific region, and Africa continent. China, India, Thailand, South Korea, and Japan are leading countries in terms of the number of gamma knife centers. The gamma knife market is therefore considerable in this region, however behind North America and Europe where the number of gamma knife centers exists far more than Asia.

Request Sample of Gamma Knife Market: https://www.coherentmarketinsights.com/insight/request-sample/408

Non-invasive precision therapy to favor the growth of global gamma knife market

Gamma knife radiotherapy involves convergence of 201 beams that can treat the tumor cell leaving precisely leaving the surrounding healthy cells undamaged. Utilizing the pre-operative diagnostic images form CT/MRI scan, the instrument provides highly accurate irradiation at the tumor site. This is a major factor that drives the usage of gamma knife radiotherapy in treating brain tumors. Application of this procedure is increasing further in trigeminal neuralgia, and arteriovenous malformations. However, gamma knife is limited to 190 positions to reach the tumor cells.

Alternative treatment options include Cyberknife, LINAC radiosurgery, conventional brain surgery, proton therapy, and modified linear accelerators. Gamma knife is the most researched and established radiosurgery. There are over 2,500 published studies for gamma knife.

To get an exclusive discount on this report : https://www.coherentmarketinsights.com/insight/request-discount/408

Potential target population for the global gamma knife market

American Brain Tumor Association:

  • Incidence of metastatic brain tumors is estimated in the range of 200,000-300,000 cases annually
  • Incidence is high in the age group of 45-64 years
  • Approximately 80,000 new cases of primary brain tumors is expected in 2017
  • Around 700,000 people in the U.S. living with a primary brain and CNS tumor as of 2016
  • American Association of Neurological Surgeons:
  • Around 150,000 new cases of trigeminal neuralgia are diagnosed annually in the U.S.
  • Disease is more common in women than men
  • International Association for the Study of Pain (IASP):
  • Global prevalence is in the range of 0.01% to 0.3% (2014)
  • Considering the current number of patients being treated i.e. 60,000, there exists a major growth potential for gamma knife market. Installation of gamma knife equipment at various locations to improve accessibility would propel the gamma knife market growth in near future.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights
1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com/

Visit Blog : http://globalresearchtrends.blogspot.in/